Traws Pharma logo

Traws Pharma

TRAW | NASDAQ
Chart Builder DCF Calculator
$0.48
-$0.04 (-7.69%)
At close: Oct 7, 2026, 4:00 PM ET
-7.69%

Rating

Updated: Oct 3, 2026
37.8
-5.2 pts
Fundamentals Average
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $7.29M
1D Range
0.47 0.52
52W Range
0.43 3.27

Valuation (TTM)

PE -0.96
PB -1.37
EV/EBITDA -0.29

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $1.00
Loading financial charts...

Profile

Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections a...

Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jul 25, 2013
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$1.00
Upside
+108.33%
Buy (0)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.